Cancer, Mankind′s Challenge

Yingyu Cui
{"title":"Cancer, Mankind′s Challenge","authors":"Yingyu Cui","doi":"10.25082/CCR.2019.01.001","DOIUrl":null,"url":null,"abstract":"Cancer, or malignant tumour, is a group of diseases defined by the uncontrollable growth of the transformed cells, and their capabilities of invasion into surrounding healthy tissues and metastasis to remote sites in the body of organisms[1, 2]. According to different origins, it can be further divided into five subtypes: carcinoma, adenocarcinoma, sarcoma, lymphoma/leukemia and myeloma. Cancer is the second leading cause of death worldwide after cardiovascular disease (GBD 2013 Mortality and Causes of Death Collaborators 2015)[3]. Usually, scientists attribute tumorigenesis to the control loss of cell proliferation, inhibition of cell differentiation and blockade of cell senescence and death at cellular level; chromosome aneuploidy[4, 5] and hyperactive telomerase[6] at sub-cellular level; excessive activation of oncogenes and excessive inhibition of anti-oncogenes, gene mutation and epigenetic modification (DNA methylation and histone acetylation, etc.)[7] at molecular level, respectively. Mutagens in in vitro environment, including physical carcinogens (UV, X-rays, etc.), chemical carcinogens (Benzopyrene, Aflatoxin B1, etc.) and biological carcinogens (DNA viruses, RNA retroviruses) can promote the transformation of benign tumours to malignant tumours with the help of factors in in vivo envi-","PeriodicalId":72728,"journal":{"name":"Current cancer reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25082/CCR.2019.01.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Cancer, or malignant tumour, is a group of diseases defined by the uncontrollable growth of the transformed cells, and their capabilities of invasion into surrounding healthy tissues and metastasis to remote sites in the body of organisms[1, 2]. According to different origins, it can be further divided into five subtypes: carcinoma, adenocarcinoma, sarcoma, lymphoma/leukemia and myeloma. Cancer is the second leading cause of death worldwide after cardiovascular disease (GBD 2013 Mortality and Causes of Death Collaborators 2015)[3]. Usually, scientists attribute tumorigenesis to the control loss of cell proliferation, inhibition of cell differentiation and blockade of cell senescence and death at cellular level; chromosome aneuploidy[4, 5] and hyperactive telomerase[6] at sub-cellular level; excessive activation of oncogenes and excessive inhibition of anti-oncogenes, gene mutation and epigenetic modification (DNA methylation and histone acetylation, etc.)[7] at molecular level, respectively. Mutagens in in vitro environment, including physical carcinogens (UV, X-rays, etc.), chemical carcinogens (Benzopyrene, Aflatoxin B1, etc.) and biological carcinogens (DNA viruses, RNA retroviruses) can promote the transformation of benign tumours to malignant tumours with the help of factors in in vivo envi-
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症,人类的挑战
癌症或恶性肿瘤是一组由转化细胞的不可控制的生长及其入侵周围健康组织和转移到生物体内远程部位的能力所定义的疾病[1,2]。根据起源的不同,可进一步分为五种亚型:癌、腺癌、肉瘤、淋巴瘤/白血病和骨髓瘤。癌症是仅次于心血管疾病的全球第二大死亡原因(GBD 2013死亡率和死亡原因合作者2015)[3]。通常,科学家将肿瘤发生归因于细胞增殖的控制丧失、细胞分化的抑制以及细胞水平上细胞衰老和死亡的阻断;亚细胞水平的染色体非整倍体[4,5]和过度活跃的端粒酶[6];分别在分子水平上过度激活致癌基因和过度抑制抗癌基因、基因突变和表观遗传学修饰(DNA甲基化和组蛋白乙酰化等)[7]。体外环境中的致癌物,包括物理致癌物(紫外线、X射线等)、化学致癌物(苯并芘、黄曲霉毒素B1等)和生物致癌物(DNA病毒、RNA逆转录病毒),在体内环境因子的帮助下,可以促进良性肿瘤向恶性肿瘤的转化-
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nanotherapeutics to cure inflammation-induced cancer Breast carcinoma in the Democratic Republic of the Congo: Characterization of hormone receptors Perspectives on chemotherapy-induced toxicities in pancreatic cancer Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy Safety and feasibility of Preoperative Simultaneous Portal Vein Embolization and Biliary Drainage in Hilar Cholangiocarcinoma prior to Hepatectomy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1